Nigral dopamine type-1 receptors are reduced in Huntington's disease: A postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding-Reference-Cited by-同舟云学术

Nigral dopamine type-1 receptors are reduced in Huntington's disease: A postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding

Published:1990-11 Issue:2 Volume:110 Page:219-227
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Filloux F.,Wagster Molly V.,Folstein Susan,Price Donald L.,Hedreen John C.,Dawson Ted M.,Wamsley James K.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference49 articles.

1. D-1 dopamine receptor changes after striatal quinolinic acid lesions;Barone;Eur. J. Pharmacol.,1987

2. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid;Beal;Nature (London),1986

3. Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function;Berent;Ann. Neurol.,1988

4. The brain in Huntington's chorea;Bird;Psychol. Med.,1978

5. Differential sensitivity of neuropeptide Y, somatostatin and NADPH-diaphorase containing neurons in rat cortex and striatum to quinolinic acid;Boegman;Brain Res.,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications;Ageing Research Reviews;2023-08

2. Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition;Proceedings of the National Academy of Sciences;2018-08-27

3. Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington’s Disease;Journal of Huntington's Disease;2018-02-24

4. Mouse Models of Huntington’s Disease;Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease;2013

5. Huntington's Disease;Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders;2011-09-21